<DOC>
	<DOCNO>NCT02295813</DOCNO>
	<brief_summary>The purpose study assess clinical laboratory safety determine pharmacokinetic profile FBF001 .</brief_summary>
	<brief_title>Safety Pharmacokinetics Study FBF001</brief_title>
	<detailed_description />
	<mesh_term>Influenza Birds</mesh_term>
	<criteria>subject 2140 year old body mass index range 18 30 Kg/m2 Any history presence clinically relevant cardiovascular , pulmonary , gastrointestinal , hepatic , renal , metabolic , haematological , neurological , osteomuscular , articular , psychiatric , systemic , ocular , infectious disease , sign acute illness Any vaccination within three month inclusion Any vaccination H5N1 virus Planned receipt vaccine study Any infectious disease within month inclusion Any history animal protein allergy , animal allergy and/or drug , food pollen allergy Who receive blood plasma derivative ( human animal ) three month precede initiation study Any medication within 14 day inclusion within 5 time elimination halflife pharmacodynamic halflife drug</criteria>
	<gender>Male</gender>
	<minimum_age>21 Years</minimum_age>
	<maximum_age>40 Years</maximum_age>
	<verification_date>November 2014</verification_date>
</DOC>